328 related articles for article (PubMed ID: 28887710)
21. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
[TBL] [Abstract][Full Text] [Related]
22. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Tsagarakis S; Terzolo M; Tabarin A; Sahdev A; Newell-Price J; Pelsma I; Marina L; Lorenz K; Bancos I; Arlt W; Dekkers OM
Eur J Endocrinol; 2023 Jul; 189(1):G1-G42. PubMed ID: 37318239
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular features of possible autonomous cortisol secretion in patients with adrenal incidentalomas.
Sbardella E; Minnetti M; D'Aluisio D; Rizza L; Di Giorgio MR; Vinci F; Pofi R; Giannetta E; Venneri MA; Vestri A; Morelli S; Lenzi A; Isidori AM
Eur J Endocrinol; 2018 May; 178(5):501-511. PubMed ID: 29510982
[TBL] [Abstract][Full Text] [Related]
24. Nonfunctioning adrenal incidentalomas with cortisol post-dexamethasone suppression test >0.9 µg/dL have a higher prevalence of cardiovascular disease than those with values ≤0.9 µg/dL.
Araujo-Castro M; Parra Ramírez P; Martín Rojas-Marcos P; García Centeno R; Gracia Gimeno P; Tomé Fernández-Ladreda M; Sampedro Núñez MA; Higueruela C; Robles Lázaro C
Endocrine; 2023 Feb; 79(2):384-391. PubMed ID: 36261701
[TBL] [Abstract][Full Text] [Related]
25. Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion.
Androulakis II; Kaltsas GA; Kollias GE; Markou AC; Gouli AK; Thomas DA; Alexandraki KI; Papamichael CM; Hadjidakis DJ; Piaditis GP
J Clin Endocrinol Metab; 2014 Aug; 99(8):2754-62. PubMed ID: 24712565
[TBL] [Abstract][Full Text] [Related]
26. Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas.
Debono M; Bradburn M; Bull M; Harrison B; Ross RJ; Newell-Price J
J Clin Endocrinol Metab; 2014 Dec; 99(12):4462-70. PubMed ID: 25238207
[TBL] [Abstract][Full Text] [Related]
27. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
[TBL] [Abstract][Full Text] [Related]
28. Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study.
Di Dalmazi G; Vicennati V; Rinaldi E; Morselli-Labate AM; Giampalma E; Mosconi C; Pagotto U; Pasquali R
Eur J Endocrinol; 2012 Apr; 166(4):669-77. PubMed ID: 22267278
[TBL] [Abstract][Full Text] [Related]
29. Chemical shift magnetic resonance imaging could predict subclinical cortisol production from an incidentally discovered adrenal mass.
Yener S; Secil M; Demir O; Ozgen Saydam B; Yorukoglu K
Clin Endocrinol (Oxf); 2018 Jun; 88(6):779-786. PubMed ID: 29498083
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the 1 mg overnight dexamethasone suppression test in the diagnosis of the subclinical Cushing's syndrome in patients with Adrenal Incidentaloma].
Li L; Han B; Dou J; Yang G; Gu W; Lü Z; Mu Y
Zhonghua Yi Xue Za Zhi; 2015 Dec; 95(48):3912-6. PubMed ID: 27122212
[TBL] [Abstract][Full Text] [Related]
31. Autonomous cortisol secretion in adrenal incidentalomas.
Araujo-Castro M; Sampedro Núñez MA; Marazuela M
Endocrine; 2019 Apr; 64(1):1-13. PubMed ID: 30847651
[TBL] [Abstract][Full Text] [Related]
32. The association of cortisol and adrenal androgen with trabecular bone score in patients with adrenal incidentaloma with and without autonomous cortisol secretion.
Kim BJ; Kwak MK; Ahn SH; Kim JS; Lee SH; Koh JM
Osteoporos Int; 2018 Oct; 29(10):2299-2307. PubMed ID: 29971455
[TBL] [Abstract][Full Text] [Related]
33. Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.
Tsagarakis S; Vassiliadi D; Thalassinos N
J Endocrinol Invest; 2006 May; 29(5):471-82. PubMed ID: 16794373
[TBL] [Abstract][Full Text] [Related]
34. Accuracy of new recommendations for adrenal incidentalomas in the evaluation of excessive cortisol secretion and follow-up.
Ruiz A; Michalopoulou T; Megia A; Näf S; Simón-Muela I; Solano E; Martínez L; Vendrell J
Eur J Clin Invest; 2019 Feb; 49(2):e13048. PubMed ID: 30412278
[TBL] [Abstract][Full Text] [Related]
35. Late-night and low-dose dexamethasone-suppressed cortisol in saliva and serum for the diagnosis of cortisol-secreting adrenal adenomas.
Deutschbein T; Unger N; Hinrichs J; Walz MK; Mann K; Petersenn S
Eur J Endocrinol; 2009 Nov; 161(5):747-53. PubMed ID: 19726566
[TBL] [Abstract][Full Text] [Related]
36. Can Imaging Predict Subclinical Cortisol Secretion in Patients With Adrenal Adenomas? A CT Predictive Score.
Mosconi C; Vicennati V; Papadopoulos D; Dalmazi GD; Morselli-Labate AM; Golfieri R; Pasquali R
AJR Am J Roentgenol; 2017 Jul; 209(1):122-129. PubMed ID: 28402131
[TBL] [Abstract][Full Text] [Related]
37. Predictors of Tumour Growth and Autonomous Cortisol Secretion Development during Follow-Up in Non-Functioning Adrenal Incidentalomas.
Araujo-Castro M; Parra Ramírez P; Robles Lázaro C; García Centeno R; Gracia Gimeno P; Fernández-Ladreda MT; Sampedro Núñez MA; Marazuela M; Escobar-Morreale HF; Valderrabano P
J Clin Med; 2021 Nov; 10(23):. PubMed ID: 34884211
[TBL] [Abstract][Full Text] [Related]
38. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
39. Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas.
Morelli V; Eller-Vainicher C; Palmieri S; Cairoli E; Salcuni AS; Scillitani A; Carnevale V; Corbetta S; Arosio M; Della Casa S; Muscogiuri G; Spada A; Chiodini I
J Clin Endocrinol Metab; 2016 Jul; 101(7):2768-75. PubMed ID: 27144939
[TBL] [Abstract][Full Text] [Related]
40. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study.
Vassilatou E; Vryonidou A; Michalopoulou S; Manolis J; Caratzas J; Phenekos C; Tzavara I
Clin Endocrinol (Oxf); 2009 May; 70(5):674-9. PubMed ID: 19067718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
